In 2022, the states with the highest death rates due to heart disease were Oklahoma, Mississippi, and Alabama. That year, there were around 257 deaths due to heart disease per 100,000 population in the state of Oklahoma. In comparison, the overall death rate from heart disease in the United States was 167 per 100,000 population. The leading cause of death in the United States Heart disease is the leading cause of death in the United States, accounting for 21 percent of all deaths in 2022. That year, cancer was the second leading cause of death, followed by unintentional injuries and COVID-19. In the United States, a person has a one in six chance of dying from heart disease. Death rates for heart disease are higher among men than women, but both have seen steady decreases in heart disease death rates since the 1950s. What are risk factors for heart disease? Although heart disease is the leading cause of death in the United States, the risk of heart disease can be decreased by avoiding known risk factors. Some of the leading preventable risk factors for heart disease include smoking, heavy alcohol use, physical inactivity, an unhealthy diet, and being overweight or obese. It is no surprise that the states with the highest rates of death from heart disease are also the states with the highest rates of heart disease risk factors. For example, Oklahoma, the state with the highest heart disease death rate, is also the state with the third-highest rate of obesity. Furthermore, Mississippi is the state with the highest levels of physical inactivity, and it has the second-highest heart disease death rate in the United States.

In 2022, Arkansas had the highest rate of death due to coronary heart disease of any U.S. state, with a rate of around *** deaths per 100,000. This statistic shows death rates for coronary heart disease in the United States in 2022, by state.

The graph displays the heart disease death rate per 100,000 people in the United States from 2000 to 2022, categorized by gender. The x-axis represents the years, ranging from 2000 to 2022, while the y-axis indicates the death rate per 100,000 individuals. The data includes three categories: "All," "Males," and "Females." Overall, there is a general downward trend in death rates for all groups from 2000 to around 2011. In 2000, the highest death rates are recorded, with "All" at 334.6, "Males" at 351.3, and "Females" at 317.2 per 100,000 people. By 2011, the rates decrease to some of their lowest values: 251.4 for "All," 251.5 for "Males," and 251.3 for "Females." After 2011, the death rates fluctuate slightly, with a slight increase observed in recent years. Notably, in 2020, there is an uptick in death rates across all categories, with "All" at 275.7, "Males" at 292.2, and "Females" at 259.5.

This statistic shows the top 20 counties in the United States based on heart disease death rate among the *** population in the period 2014-2016. The heart disease death rate of the *** population in Franklin county in the state of Louisiana was the highest, with ******* deaths from heart disease per every 100,000 of that age group.

In 2022, the state with the highest death rate from hypertension was Mississippi, with around 18 deaths per 100,000 population. Hypertension, or high blood pressure, can increase the risk of a number of health issues including heart disease, stroke, and kidney disease. This statistic shows the death rate due to hypertension in the United States in 2022, by state.

Heart disease is currently the leading cause of death in the United States. In 2022, COVID-19 was the fourth leading cause of death in the United States, accounting for almost six percent of all deaths that year. The leading causes of death worldwide are similar to those in the United States. However, diarrheal diseases and neonatal conditions are major causes of death worldwide, but are not among the leading causes in the United States. Instead, accidents and chronic liver disease have a larger impact in the United States.

Racial differences

In the United States, there exist slight differences in leading causes of death depending on race and ethnicity. For example, assault, or homicide, accounts for around three percent of all deaths among the Black population but is not even among the leading causes of death for other races and ethnicities. However, heart disease and cancer are still the leading causes of death for all races and ethnicities.

Leading causes of death among men vs women

Similarly, there are also differences in the leading causes of death in the U.S. between men and women. For example, among men, intentional self-harm accounts for around two percent of all deaths but is not among the leading causes of death among women. On the other hand, influenza and pneumonia account for more deaths among women than men.

Create maps of U.S. heart disease death rates by county. Data can be stratified by age, race/ethnicity, and sex. Visit the CDC/DHDSP Atlas of Heart Disease and Stroke for additional data and maps. Atlas of Heart Disease and StrokeData SourceMortality data were obtained from the National Vital Statistics System. Bridged-Race Postcensal Population Estimates were obtained from the National Center for Health Statistics. International Classification of Diseases, 10th Revision (ICD-10) codes: I00-I09, I11, I13, I20-I51; underlying cause of death.Data DictionaryData for counties with small populations are not displayed when a reliable rate could not be generated. These counties are represented in the data with values of '-1.' CDC/DHDSP excludes these values when classifying the data on a map, indicating those counties as 'Insufficient Data.' Data field names and descriptionsstcty_fips: state FIPS code + county FIPS codeOther fields use the following format: RRR_S_aaaa (e.g., API_M_35UP)   RRR: 3 digits represent race/ethnicity     All - Overall     AIA - American Indian and Alaska Native, non-Hispanic     API - Asian and Pacific Islander, non-Hispanic     BLK - Black, non-Hispanic     HIS - Hispanic     WHT - White, non-Hispanic   S: 1 digit represents sex     A - All    F - Female     M - Male aaaa: 4 digits represent age. The first 2 digits are the lower bound for age and the last 2 digits are the upper bound for age. 'UP' indicates the data includes the maximum age available and 'LT' indicates ages less than the upper bound.  Example: The column 'BLK_M_65UP' displays rates per 100,000 black men aged 65 years and older.MethodologyRates are calculated using a 3-year average and are age-standardized in 10-year age groups using the 2000 U.S. Standard Population. Rates are calculated and displayed per 100,000 population. Rates were spatially smoothed using a Local Empirical Bayes algorithm to stabilize risk by borrowing information from neighboring geographic areas, making estimates more statistically robust and stable for counties with small populations. Data for counties with small populations are coded as '-1' when a reliable rate could not be generated. County-level rates were generated when the following criteria were met over a 3-year time period within each of the filters (e.g., age, race, and sex).At least one of the following 3 criteria: At least 20 events occurred within the county and its adjacent neighbors.ORAt least 16 events occurred within the county.ORAt least 5,000 population years within the county.AND all 3 of the following criteria:At least 6 population years for each age group used for age adjustment if that age group had 1 or more event.The number of population years in an age group was greater than the number of events.At least 100 population years within the county.More Questions?Interactive Atlas of Heart Disease and StrokeData SourcesStatistical Methods

MMWR Surveillance Summary 66 (No. SS-1):1-8 found that nonmetropolitan areas have significant numbers of potentially excess deaths from the five leading causes of death. These figures accompany this report by presenting information on potentially excess deaths in nonmetropolitan and metropolitan areas at the state level. They also add additional years of data and options for selecting different age ranges and benchmarks. Potentially excess deaths are defined in MMWR Surveillance Summary 66(No. SS-1):1-8 as deaths that exceed the numbers that would be expected if the death rates of states with the lowest rates (benchmarks) occurred across all states. They are calculated by subtracting expected deaths for specific benchmarks from observed deaths. Not all potentially excess deaths can be prevented; some areas might have characteristics that predispose them to higher rates of death. However, many potentially excess deaths might represent deaths that could be prevented through improved public health programs that support healthier behaviors and neighborhoods or better access to health care services. Mortality data for U.S. residents come from the National Vital Statistics System. Estimates based on fewer than 10 observed deaths are not shown and shaded yellow on the map. Underlying cause of death is based on the International Classification of Diseases, 10th Revision (ICD-10) Heart disease (I00-I09, I11, I13, and I20–I51) Cancer (C00–C97) Unintentional injury (V01–X59 and Y85–Y86) Chronic lower respiratory disease (J40–J47) Stroke (I60–I69) Locality (nonmetropolitan vs. metropolitan) is based on the Office of Management and Budget’s 2013 county-based classification scheme. Benchmarks are based on the three states with the lowest age and cause-specific mortality rates. Potentially excess deaths for each state are calculated by subtracting deaths at the benchmark rates (expected deaths) from observed deaths. Users can explore three benchmarks: “2010 Fixed” is a fixed benchmark based on the best performing States in 2010. “2005 Fixed” is a fixed benchmark based on the best performing States in 2005. “Floating” is based on the best performing States in each year so change from year to year. SOURCES CDC/NCHS, National Vital Statistics System, mortality data (see http://www.cdc.gov/nchs/deaths.htm); and CDC WONDER (see http://wonder.cdc.gov). REFERENCES Moy E, Garcia MC, Bastian B, Rossen LM, Ingram DD, Faul M, Massetti GM, Thomas CC, Hong Y, Yoon PW, Iademarco MF. Leading Causes of Death in Nonmetropolitan and Metropolitan Areas – United States, 1999-2014. MMWR Surveillance Summary 2017; 66(No. SS-1):1-8. Garcia MC, Faul M, Massetti G, Thomas CC, Hong Y, Bauer UE, Iademarco MF. Reducing Potentially Excess Deaths from the Five Leading Causes of Death in the Rural United States. MMWR Surveillance Summary 2017; 66(No. SS-2):1–7.

2019 to 2021, 3-year average. Rates are age-standardized. County rates are spatially smoothed. The data can be viewed by sex and race/ethnicity. Data source: National Vital Statistics System. Additional data, maps, and methodology can be viewed on the Interactive Atlas of Heart Disease and Stroke https://www.cdc.gov/heart-disease-stroke-atlas/about/index.html

The dataset contains risk-adjusted mortality rates, quality ratings, and number of deaths and cases for 6 medical conditions treated (Acute Stroke, Acute Myocardial Infarction, Heart Failure, Gastrointestinal Hemorrhage, Hip Fracture and Pneumonia) and 3 procedures performed (Carotid Endarterectomy, Pancreatic Resection, and Percutaneous Coronary Intervention) in California hospitals. The 2023 IMIs were generated using AHRQ Version 2024, while previous years' IMIs were generated with older versions of AHRQ software (2022 IMIs by Version 2023, 2021 IMIs by Version 2022, 2020 IMIs by Version 2021, 2019 IMIs by Version 2020, 2016-2018 IMIs by Version 2019, 2014 and 2015 IMIs by Version 5.0, and 2012 and 2013 IMIs by Version 4.5). The differences in the statistical method employed and inclusion and exclusion criteria using different versions can lead to different results. Users should not compare trends of mortality rates over time. However, many hospitals showed consistent performance over years; “better” performing hospitals may perform better and “worse” performing hospitals may perform worse consistently across years. This dataset does not include conditions treated or procedures performed in outpatient settings. Please refer to statewide table for California overall rates: https://data.chhs.ca.gov/dataset/california-hospital-inpatient-mortality-rates-and-quality-ratings/resource/af88090e-b6f5-4f65-a7ea-d613e6569d96

In 2022, coronary heart disease accounted for around ** percent of all cardiovascular disease deaths in the United States. This statistic shows the distribution of cardiovascular disease deaths in the U.S. in 2022, by type.

This dataset includes count and age-adjusted rate per 100,000 population of mortality (death) for 9 chronic conditions by year and by geography (i.e., the state and 35 health districts). Data set includes mortality data from 2016 to the most current year for Virginia residents.

The 9 chronic conditions include: Alzheimer’s Disease, Cardiovascular disease, Chronic Kidney Disease, Chronic Obstructive Pulmonary Disease, Asthma, Diabetes, Stroke, Heart Disease, and Hypertension. The International Classification of Diseases, Tenth Revision (ICD-10) codes are used to identify chronic disease mortality indicators. Definitions are based on Underlying Cause of Death on the death certificate outlined in the “Underlying Cause-of-Death List for Tabulating Mortality Statistics” instruction manual developed by the National Center for Health Statistics at the Centers for Disease Control and Prevention (CDC) found on OCR Document (cdc.gov).

United States US: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data was reported at 14.600 % in 2016. This records an increase from the previous number of 14.300 % for 2015. United States US: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data is updated yearly, averaging 14.600 % from Dec 2000 (Median) to 2016, with 5 observations. The data reached an all-time high of 18.000 % in 2000 and a record low of 14.300 % in 2015. United States US: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted Average;

This dataset includes count and age-adjusted rate per 100,000 population of mortality (death) in Virginia for 9 chronic conditions by year and by demographic groups (i.e., age, race/ethnicity, and sex). Age group values include 0 to 17 years, 18 to 44 years, 45 to 54 years, 55 to 64 years, 65 to 74 years, and 75+ years. Race/ethnicity values include American Indian or Alaska Native, Asian or Pacific Islander, Black or African American, Hispanic or Latino, and White. Sex values include female and male. Data set includes mortality data from 2016 to the most current year for Virginia residents.

The 9 chronic conditions include: Alzheimer’s Disease, Cardiovascular disease, Chronic Kidney Disease, Chronic Obstructive Pulmonary Disease, Asthma, Diabetes, Stroke, Heart Disease, and Hypertension. The International Classification of Diseases, Tenth Revision (ICD-10) codes are used to identify chronic disease mortality indicators. Definitions are based on Underlying Cause of Death on the death certificate outlined in the “Underlying Cause-of-Death List for Tabulating Mortality Statistics” instruction manual developed by the National Center for Health Statistics at the Centers for Disease Control and Prevention (CDC) found here OCR Document (cdc.gov).

As of 2023, the countries with the highest death rates worldwide were Monaco, Bulgaria, and Latvia. In these countries, there were ** to ** deaths per 1,000 people. The country with the lowest death rate is Qatar, where there is just *** death per 1,000 people. Leading causes of death The leading causes of death worldwide are, by far, cardiovascular diseases, accounting for ** percent of all deaths in 2021. That year, there were **** million deaths worldwide from ischaemic heart disease and **** million from stroke. Interestingly, a worldwide survey from that year found that people greatly underestimate the proportion of deaths caused by cardiovascular disease, but overestimate the proportion of deaths caused by suicide, interpersonal violence, and substance use disorders. Death in the United States In 2023, there were around **** million deaths in the United States. The leading causes of death in the United States are currently heart disease and cancer, accounting for a combined ** percent of all deaths in 2023. Lung and bronchus cancer is the deadliest form of cancer worldwide, as well as in the United States. In the U.S. this form of cancer is predicted to cause around ****** deaths among men alone in the year 2025. Prostate cancer is the second-deadliest cancer for men in the U.S. while breast cancer is the second deadliest for women. In 2023, the tenth leading cause of death in the United States was COVID-19. Deaths due to COVID-19 resulted in a significant rise in the total number of deaths in the U.S. in 2020 and 2021 compared to 2019, and it was the third leading cause of death in the U.S. during those years.

ObjectiveSystemic arterial hypertension (HT) is a major modifiable risk factor for cardiovascular disease (CVDs), associated with all-cause death (ACD). Understanding its progression from the early state to late complications should lead to more timely intensification of treatment. This study aimed to construct a real-world cohort profile of HT and to estimate transition probabilities from the uncomplicated state to any of these long-term complications; chronic kidney disease (CKD), coronary artery disease (CAD), stroke, and ACD.MethodsThis real-world cohort study used routine clinical practice data for all adult patients diagnosed with HT in the Ramathibodi Hospital, Thailand from 2010 to 2022. A multi-state model was developed based on the following: state 1-uncomplicated HT, 2-CKD, 3-CAD, 4-stroke, and 5-ACD. Transition probabilities were estimated using Kaplan-Meier method.ResultsA total of 144,149 patients were initially classified as having uncomplicated HT. The transition probabilities (95% CI) from the initial state to CKD, CAD, stroke, and ACD at 10-years were 19.6% (19.3%, 20.0%), 18.2% (17.9%, 18.6%), 7.4% (7.1%, 7.6%), and 1.7% (1.5%, 1.8%), respectively. Once in the intermediate-states of CKD, CAD, and stroke, 10-year transition probabilities to death were 7.5% (6.8%, 8.4%), 9.0% (8.2%, 9.9%), and 10.8% (9.3%, 12.5%).ConclusionsIn this 13-year cohort, CKD was observed as the most common complication, followed by CAD and stroke. Among these, stroke carried the highest risk of ACD, followed by CAD and CKD. These findings provide improved understanding of disease progression to guide appropriate prevention measures. Further investigations of prognostic factors and treatment effectiveness are warranted.

BackgroundAlthough most countries face increasing population levels of obesity and diabetes their effect on coronary heart disease (CHD) mortality has not been often studied in small island developing states (SIDs) where obesity rates are among the highest in the world. We estimated the relative contributions of treatments and cardiovascular risk factors to the decline in CHD mortality from 1990 to 2012 in the Caribbean island, Barbados.MethodsWe used the IMPACT CHD mortality model to estimate the effect of increased coverage of effective medical/surgical treatments and changes in major CHD risk factors on mortality trends in 2012 compared with 1990. We calculated deaths prevented or postponed (DPPs) for each model risk factor and treatment group. We obtained data from WHO Mortality database, population denominators from the Barbados Statistical Service stratified by 10-year age group (ages 25–34 up to 85 plus), population-based risk factor surveys, Global Burden of Disease and Barbados’ national myocardial infarction registry. Monte Carlo probabilistic sensitivity analysis was performed.ResultsIn 1990 the age-standardized CHD mortality rate was 109.5 per 100,000 falling to 55.3 in 2012. Implementation of effective treatment accounted for 56% DPPs (95% (Uncertainty Interval (UI) 46%, 68%), mostly due to the introduction of treatments immediately after acute myocardial infarction (AMI) (14%) and unstable angina (14%). Overall, risk factors contributed 19% DPPs (95% UI 6% to 34%) mostly attributed to decline in cholesterol (18% DPPs, 95% UI 12%, 26%). Adverse trends in diabetes: 14% additional deaths(ADs) 95% UI 8% to 21% ADs) and BMI (2% ADs 95%UI 0 to 5% ADs) limited potential for risk factor gains.ConclusionsGiven the significant negative impact of obesity/diabetes on mortality in this analysis, research that explores factors affecting implementation of evidenced-based preventive strategies is needed. The fact that most of the decline in CHD mortality in Barbados was due to treatment provides an example for SIDs about the advantages of universal access to care and treatment.

United States US: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data was reported at 17.500 NA in 2016. This records an increase from the previous number of 17.200 NA for 2015. United States US: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data is updated yearly, averaging 17.500 NA from Dec 2000 (Median) to 2016, with 5 observations. The data reached an all-time high of 21.600 NA in 2000 and a record low of 17.200 NA in 2015. United States US: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United States – Table US.World Bank.WDI: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;

BackgroundCardiovascular diseases (CVDs) are not only the primary cause of mortality in China but also represent a significant financial burden. The World Health Organization highlight that as China undergoes rapid socioeconomic development, its disease spectrum is gradually shifting towards that of developed countries, with increasing prevalence of lifestyle-related diseases such as ischemic heart disease and stroke. We reviewed the rates and trends of CVDs incidence, mortality and disability-adjusted life years (DALYs) burden in China and compared them with those in the United States (US) and Japan for formulating CVDs control policies.MethodsData on CVDs incidence, death and DALYs in China, the US and Japan were obtained from the GBD 2019 database. The Joinpoint regression model was used to analyze the trends in CVDs incidence and mortality in China, the US and Japan, calculate the annual percentage change and determine the best-fitting inflection points.ResultsIn 2019, there were approximately 12,341,074 new diagnosed cases of CVDs in China, with 4,584,273 CVDs related deaths, causing 91,933,122 DALYs. The CVDs age-standardized incidence rate (ASIR) in China (538.10/100,000) was lower than that in the US and globally, while age-standardized death rate (ASDR) (276.9/100,000) and age-standardized DALY rate (6,463.47/100,000) were higher than those in the two regions. Compared with the US and Japan, from 1990 to 2019, the CVDs incidence rate in China showed an increasing trend, with a lower annual decrease in ASDR and a younger age structure of disease burden. Furthermore, the disease spectrum in China changed minimally, with stroke, ischemic heart disease, and hypertensive heart disease being the top three leading CVDs diseases in terms of incidence and disease burden, also being the major causes of CVDs in the US and Japan.ConclusionThe prevention and control of CVDs is a global issue. The aging population and increasing unhealthy lifestyles will continue to increase the burden in China. Therefore, relevant departments in China should reference the established practices for CVDs control in developed countries while considering the diversity of CVDs in different regions when adjusting national CVDs control programs.

The leading causes of death in Massachusetts are cancer, heart disease, unintentional injury, stroke, and chronic lower respiratory disease. These mortality rates tend to be higher for people of color; and Black residents have a higher premature mortality rate overall and Asian residents have a higher rate of mortality due to stroke.